tiprankstipranks
Advertisement
Advertisement

PCKAILE Stock Latest News

Kailera Therapeutics Emphasizes Supply Chain Leadership for Obesity Pipeline
Private CompaniesKailera Therapeutics Emphasizes Supply Chain Leadership for Obesity Pipeline
15d ago
KAILE
Kailera Therapeutics Emphasizes Supply Chain Leadership for Obesity Pipeline Execution
PremiumPrivate Companies
Kailera Therapeutics Emphasizes Supply Chain Leadership for Obesity Pipeline Execution
16d ago
KAILE
Employee Engagement Spotlight Underscores Kailera Therapeutics’ Culture Focus
PremiumPrivate Companies
Employee Engagement Spotlight Underscores Kailera Therapeutics’ Culture Focus
23d ago
KAILE
Kailera Therapeutics Highlights Employee Engagement and Culture Focus
PremiumPrivate Companies
Kailera Therapeutics Highlights Employee Engagement and Culture Focus
24d ago
KAILE
Kailera Therapeutics Emphasizes Non-Clinical Leadership and Obesity Pipeline Focus
PremiumPrivate Companies
Kailera Therapeutics Emphasizes Non-Clinical Leadership and Obesity Pipeline Focus
29d ago
KAILE
Leadership Focus Highlights Execution Strategy in Obesity Pipeline
PremiumPrivate CompaniesLeadership Focus Highlights Execution Strategy in Obesity Pipeline
30d ago
KAILE
Kailera Therapeutics Highlights Leadership Focus on Quality and Patient-Centric Innovation
Premium
Private Companies
Kailera Therapeutics Highlights Leadership Focus on Quality and Patient-Centric Innovation
1M ago
KAILE
Leadership Focus on Quality and Mission at Kailera Therapeutics
Premium
Private Companies
Leadership Focus on Quality and Mission at Kailera Therapeutics
1M ago
KAILE
Kailera Therapeutics Emphasizes Strategic Focus on Evidence‑Based Obesity Care
PremiumPrivate Companies
Kailera Therapeutics Emphasizes Strategic Focus on Evidence‑Based Obesity Care
1M ago
KAILE
Kailera Therapeutics Highlights Strategic Focus on Obesity Care Advocacy
PremiumPrivate Companies
Kailera Therapeutics Highlights Strategic Focus on Obesity Care Advocacy
1M ago
KAILE
Kailera Therapeutics Highlights Strategic Focus on Global Obesity Care
PremiumPrivate Companies
Kailera Therapeutics Highlights Strategic Focus on Global Obesity Care
1M ago
KAILE
Kailera Therapeutics Emphasizes Diversified Pipeline in Global Obesity Market
PremiumPrivate Companies
Kailera Therapeutics Emphasizes Diversified Pipeline in Global Obesity Market
1M ago
KAILE
Kailera Therapeutics Emphasizes Strategic Focus on Obesity Therapies
PremiumPrivate CompaniesKailera Therapeutics Emphasizes Strategic Focus on Obesity Therapies
1M ago
KAILE
Kailera Therapeutics Emphasizes Obesity Therapeutics in Global Advocacy Initiative
Premium
Private Companies
Kailera Therapeutics Emphasizes Obesity Therapeutics in Global Advocacy Initiative
1M ago
KAILE
Kailera Therapeutics Highlights Positive Phase 2 Data for Oral Obesity Therapy
Premium
Private Companies
Kailera Therapeutics Highlights Positive Phase 2 Data for Oral Obesity Therapy
2M ago
KAILE
Kailera Advances Global Ribupatide Obesity Franchise on Strong Oral Phase 2 Data
PremiumPrivate Companies
Kailera Advances Global Ribupatide Obesity Franchise on Strong Oral Phase 2 Data
2M ago
KAILE
Kailera Therapeutics Expands Clinical Data Management to Support Growing Metabolic Disease Pipeline
PremiumPrivate Companies
Kailera Therapeutics Expands Clinical Data Management to Support Growing Metabolic Disease Pipeline
2M ago
KAILE
Kailera Therapeutics Highlights Mission-Driven Culture in Obesity Treatment Focus
PremiumPrivate Companies
Kailera Therapeutics Highlights Mission-Driven Culture in Obesity Treatment Focus
2M ago
KAILE
Kailera Therapeutics CEO Highlights Obesity Pipeline at World Economic Forum in Davos
PremiumPrivate Companies
Kailera Therapeutics CEO Highlights Obesity Pipeline at World Economic Forum in Davos
3M ago
KAILE
Kailera Therapeutics Launches Phase 3 Obesity Program for Ribupatide and Highlights Hengrui Partnership at JPM 2026
PremiumPrivate CompaniesKailera Therapeutics Launches Phase 3 Obesity Program for Ribupatide and Highlights Hengrui Partnership at JPM 2026
3M ago
KAILE
Kailera Therapeutics – Weekly Recap
Premium
Private Companies
Kailera Therapeutics – Weekly Recap
3M ago
KAILE
Kailera Therapeutics Advances Obesity Candidate Ribupatide Into Global Phase 3 Trial
Premium
Private Companies
Kailera Therapeutics Advances Obesity Candidate Ribupatide Into Global Phase 3 Trial
3M ago
KAILE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >